IBD

Perioperative

Geriatric Track

APP Track

DEI Track

Live Stream

LiveQ&A

Perioperative Optimization of the IBD Patient: How Many Biologics is Too Many?

Co-Moderator(s)

• 

  Jaime Bohl, MD

  Professor
  Virginia Commonwealth University
  Richmond, Virginia, United States

  All of the relevant financial relationships listed below have been mitigated.
  This individual has no financial relationships with ineligible companies.
• 

  Kinga Olortegui, MD, MS, FACS

  Assistant Professor
  UChicago Medicine
  Chicago, Illinois, United States

  All of the relevant financial relationships listed below have been mitigated.
  This individual has no financial relationships with ineligible companies.

CME Credit: 0.75
Self-Assessment Credit: 0.75
Contact Hours: 0.75

Inflammatory Bowel Disease is a complex chronic disease requiring a multidisciplinary approach to care. Despite advances in medical management, many patients will eventually need operative intervention. This symposium will discuss different aspects of medical management and perioperative optimization of the IBD patient.

Presentations:

• 12:30 PM – 12:35 PM PT

  Introduction
  

  Co-Moderator: Jaime Bohl, MD – Virginia Commonwealth University

  Co-Moderator: Kinga S. Olortegui, MD, MS, FACS – UChicago Medicine
• 12:35 PM – 12:43 PM PT

  IBD Management in Unique Patient Populations
  

  Faculty: Sanjay Mohanty, MD (he/him/his) – Indiana University School of Medicine
• 12:43 PM – 12:51 PM PT

  New IBD Medications and their Use in the Perioperative Setting
  

  Faculty: Sushila Dalal, MD (she/her/hers) – University of Chicago Medicine
• 12:51 PM – 12:59 PM PT

  Management of IBD Medications in the Perioperative Setting
  

  Faculty: Lisa Marie Cannon, MD – University of Rochester Medical Center
• 12:59 PM – 1:07 PM PT

  How Medication Effects Interoperative Decisions
  

  Faculty: Athur Harikrishnan, MBBS, MS, MPhil, FRCS – Sheffield Teaching Hospitals, Sheffield, UK
• 1:08 PM – 1:20 PM PT

  Question and Answer with Polling